Peisker A, Raschke GF, Fahmy
MD, Guentsch A, Roshanghias
K, Hennings J, Schultze-Mosgau
S. Salivary MMP-9 in the detection of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2017 May 1;22 (3):e270-5.
doi:10.4317/medoral.21626
http://dx.doi.org/doi:10.4317/medoral.21626
|
1. Wolff KD, Follmann M, Nast A. The diagnosis and treatment of
oral cavity cancer. Dtsch Arztebl Int. 2012;109:829-35. |
|
|
|
|
|
2. Messadi DV. Diagnostic aids for detection
of oral precancerous conditions.
Int J Oral Sci.
2013;5:59-65. |
|
|
|
|
|
3. Adami GR, Adami AJ. Looking in the mouth for noninvasive
gene expression-based methods
to detect oral, oropharyngeal, and systemic cancer. ISRN Oncol.
2012;2012:931301. |
|
|
|
|
|
4. Mehrotra R, Sharma N, Umudum H, Ceyhan K, Rezanko T. The role of cytopathology in diagnosing HPV
induced oropharyngeal lesions. Diagn Cytopathol. 2012;40:839-43. |
|
|
|
|
|
5. Scully C, Kirby J. Statement on mouth cancer diagnosis and prevention. Br Dent J.
2014;216:37-8. |
|
|
|
|
|
6. Kalmar JR. Advances in the detection and diagnosis of oral precancerous
and cancerous lesions.
Oral Maxillofac Surg Clin North Am. 2006;18:465-82. |
|
|
|
|
|
7. Cheng YS, Rees T, Wright J. Updates Regarding Diagnostic Adjuncts for Oral Squamous Cell Carcinoma. Tex Dent J.
2015;132:538-49. |
|
|
|
|
|
8. Patton LL, Epstein JB, Kerr AR.
Adjunctive techniques for oral cancer examination and lesion
diagnosis: a systematic review
of the literature. J Am Dent Assoc. 2008;139:896-905. |
|
|
|
|
|
9. Cheng YS, Rees T, Wright J. A review of research on salivary biomarkers
for oral cancer detection. Clin Transl Med. 2014;3:3. |
|
|
|
|
|
10. Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007;133:613-7. |
|
|
|
|
|
11. Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I, et al. Salivary analysis of oral cancer biomarkers. Br J Cancer. 2009;101:1194-8. |
|
|
|
|
|
12. Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J. 2012;6:126-30. |
|
|
|
|
|
13. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-4. |
|
|
|
|
|
14. Pories SE, Zurakowski D, Roy R,
Lamb CC, Raza S, Exarhopoulos
A, et al. Urinary metalloproteinases:
noninvasive biomarkers for breast cancer
risk assessment. Cancer Epidemiol Biomarkers Prev.
2008;17:1034-42. |
|
|
|
|
|
15. Smith ER, Zurakowski D, Saad A, Scott RM,
Moses MA. Urinary biomarkers predict brain tumor presence and
response to therapy. Clin Cancer Res.
2008;14:2378-86. |
|
|
|
|
|
16. Chen L, Sun B, Zhang S, Zhao X, He Y, Zhao S, et al. Influence of microenvironments on microcirculation patterns and tumor invasion-related
protein expression in
melanoma. Oncol Rep. 2009;21:917-23. |
|
|
|
|
|
17. Patterson
BC, Sang QA. Angiostatin-converting
enzyme activities of
human matrilysin (MMP-7) and gelatinase
B/type IV collagenase
(MMP-9). J Biol Chem.
1997;272:28823-5. |
|
|
|
|
|
18. Iurlaro M, Loverro G, Vacca A, Cormio G, Ribatti D, Minischetti M, et
al. Angiogenesis extent
and expression of matrix metalloproteinase- 2 and -9 correlate
with upgrading and myometrial invasion in
endometrial carcinoma. Eur J Clin
Invest. 1999;29:793-801. |
|
|
|
|
|
19. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman
R, D'Orazi G, Murphy AN, et al. Type
IV collagenase(s) and TIMPs
modulate endothelial cell morphogenesis in vitro. J Cell Physiol. 1993;156:235-46. |
|
|
|
|
|
20. Thomas GJ,
Lewis MP, Hart IR, Marshall JF, Speight
PM. AlphaVbeta6 integrin promotes
invasion of squamous
carcinoma cells through
up-regulation of matrix
metalloproteinase-9. Int J Cancer.
2001;92:641-50. |
|
|
|
|
|
21. Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, et
al. CD44 expression and its
relationship with MMP-9, clinicopathological factors and
survival in oral squamous
cell carcinoma. Oral Oncol.
2007;43:51-9. |
|
|
|
|
|
22. Peisker A, Raschke GF, Guentsch A, Luepke P, Roshanghias K, Schultze-Mosgau
S. Evaluation of a post-treatment
follow-up program in patients with oral squamous cell carcinoma. Clin Oral Investig.
2016;21:135-141. |
|
|
|
|
|
23. Camisasca DR, Silami MA,
Honorato J, Dias FL, de Faria
PA, Lourenco Sde Q. Oral squamous cell carcinoma: clinicopathological features in
patients with and without recurrence. ORL J Otorhinolaryngol Relat Spec. 2011;73:170-6. |
|
|
|
|
|
24. Ebrahimi A, Clark JR, Zhang WJ, Elliott
MS, Gao K, Milross CG, et
al. Lymph node ratio as an independent prognostic factor in oral squamous
cell carcinoma. Head Neck.
2011;33:1245-51. |
|
|
|
|
|
25. Yakob M, Fuentes L, Wang MB, Abemayor
E, Wong DT. Salivary biomarkers
for detection of oral squamous cell carcinoma - current state and recent advances. Curr Oral Health Rep.
2014;1:133-41. |
|